Orthofix awarded $150 mil. in damages from Biomet in jury decision on external fixation devices.
This article was originally published in The Gray Sheet
BIOMET TO APPEAL JURY'S $150 MIL. AWARD TO ORTHOFIX, the Warsaw, Indiana-based company says. In a verdict announced June 2, a jury in the U.S. District Court in Camden, New Jersey, awarded approximately $50 mil. in compensatory damages and $100 mil. in punitive damages to three of Orthofix International's subsidiaries after finding that Biomet's EBI Medical Systems subsidiary breached a 1990 distribution agreement between the firms.
You may also be interested in...
Punitive damages related to breach of contract case filed by Orthofix in 1995 are reduced from $50 mil. to $1 mil. by the U.S. Court of Appeals for the Third Circuit, Biomet reports. However, the court upholds the original compensatory damages of $49 mil. related to the breach of contract suit found in favor of Orthofix in 1997 (1"The Gray Sheet" June 9, 1997, I&W-5). As a result, Biomet will record a $49.9 mil. charge plus interest against pre-tax earnings for the quarter ended May 31. Biomet also says that it is still "considering further legal challenges" in the case
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.